TW200742582A - A method of building a healthiness for a mammal - Google Patents

A method of building a healthiness for a mammal

Info

Publication number
TW200742582A
TW200742582A TW095116627A TW95116627A TW200742582A TW 200742582 A TW200742582 A TW 200742582A TW 095116627 A TW095116627 A TW 095116627A TW 95116627 A TW95116627 A TW 95116627A TW 200742582 A TW200742582 A TW 200742582A
Authority
TW
Taiwan
Prior art keywords
healthiness
mammal
building
treatment
present
Prior art date
Application number
TW095116627A
Other languages
English (en)
Inventor
Yi Li
Michael Chopp
Original Assignee
Ford Henry Health System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/431,290 external-priority patent/US8017112B2/en
Application filed by Ford Henry Health System filed Critical Ford Henry Health System
Publication of TW200742582A publication Critical patent/TW200742582A/zh

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
TW095116627A 2006-05-09 2006-05-10 A method of building a healthiness for a mammal TW200742582A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/431,290 US8017112B2 (en) 1999-05-14 2006-05-09 Transplantation of bone marrow stromal cells for treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
TW200742582A true TW200742582A (en) 2007-11-16

Family

ID=57914137

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095116627A TW200742582A (en) 2006-05-09 2006-05-10 A method of building a healthiness for a mammal

Country Status (1)

Country Link
TW (1) TW200742582A (zh)

Similar Documents

Publication Publication Date Title
NL301145I1 (zh)
EP1818344A4 (en) METHOD FOR SYNTHESIZING RETICULATED HYALURONIC ACID GEL
TN2009000285A1 (en) Human cytomegalovirus neutralising antibodies and use thereof
PT1827441E (pt) Combinações para o tratamento de doenças que envolvem proliferação celular
MX2010004219A (es) Agentes de enlace de cd19 y usos de los mismos.
EA201000559A1 (ru) Композиции и способы применения антител к склеростину
SG170809A1 (en) Diarylthiohydantoin compounds
EP1947942A4 (en) METHODS OF BONE TREATMENT BY MODULATION OF A METABOLIC PATH OR SIGNALING OF ARACHIDONIC ACID
PH12014501180A1 (en) New use 938
EP1986954A4 (en) SYSTEM FOR TREATING HYDROGEN SULFIDE
EP1904964A4 (en) HANDLING MANAGEMENT SYSTEM
GB2409928B (en) Improvements relating to ion implantation
PL2274005T3 (pl) Leczenie chorób nowotworowych z użyciem konwertazy angiotensyny 2 (ace2)
ZA200802414B (en) Process for the preparation of (meth)acrylates of tetra- or polyhydric alcohols
EP1863940A4 (en) METHOD OF RISK MANAGEMENT FOR NATALIZUMAB TREATED PATIENTS
ZA200802935B (en) Use of lactobacillus for treatment of autoimmune diseases
IL179129A0 (en) Kit for treatment of cancer
EP1858524A4 (en) COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNE DISEASES AND RELATED DISEASES
IL240394A0 (en) Treatment of multiple sclerosis with h 1– campath
MX2010000979A (es) Metodos y composiciones para tratar enfermedad autoinmune.
EP1987165A4 (en) Gene with influence on the human memory
ZA201103131B (en) Methods to reduce b-helper t cells to treat autoimmune diseases
SG142306A1 (en) Methods for neuroprotection
TW200742582A (en) A method of building a healthiness for a mammal
SI2084183T1 (sl) Pegilirani pth kot modulatorji pth receptorja in njihove uporabe